1992
DOI: 10.1002/cne.903260206
|View full text |Cite
|
Sign up to set email alerts
|

Electron microscopic localization of photoaffinity‐labelled delta opioid receptors in the neostriatum of the rat

Abstract: The distribution of delta opioid receptors, selectively labelled in vitro with the photoaffinity probe monoiodo azido-DTLET ([D-Thr2,pN3Phe4, Leu5]enkephaly-Thr6), was analyzed by light and electron microscopic radioautography in sections from rat neostriatum. Preliminary experiments indicated that up to 65% of specific 125I-azido-DTLET binding to rat striatal sections was still detectable following prefixation of the brain with 0.5% glutaraldehyde. These experiments also showed that up to 20-30% of the specif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
32
0

Year Published

1994
1994
2021
2021

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 83 publications
2
32
0
Order By: Relevance
“…Our data demonstrate that Ͼ70% of both presynaptic and postsynaptic KAR subunit immunoreactivity is expressed intracellularly and that almost two-thirds of the plasma membrane-bound KARS are extrasynaptic. This pattern of distribution resembles that of G-protein-coupled metabotropic receptors which, for the most part, are expressed intracellularly or at nonsynapic sites along plasma membrane (Pasquini et al, 1992;Wang et al, 1997;Bernard et al, 1999;Hanson and Smith, 1999;Smith et al, 2000Smith et al, , 2001. Interestingly, both the presynaptic and postsynaptic effects of kainate receptors are consistent with those of metabotropic glutamate receptor functions (for review, see Conn and Pin, 1997;Anwyl, 1999;Cartmell and Schoepp, 2000).…”
Section: Subcellular Localization Of Kainate Receptor Subunitsmentioning
confidence: 58%
“…Our data demonstrate that Ͼ70% of both presynaptic and postsynaptic KAR subunit immunoreactivity is expressed intracellularly and that almost two-thirds of the plasma membrane-bound KARS are extrasynaptic. This pattern of distribution resembles that of G-protein-coupled metabotropic receptors which, for the most part, are expressed intracellularly or at nonsynapic sites along plasma membrane (Pasquini et al, 1992;Wang et al, 1997;Bernard et al, 1999;Hanson and Smith, 1999;Smith et al, 2000Smith et al, , 2001. Interestingly, both the presynaptic and postsynaptic effects of kainate receptors are consistent with those of metabotropic glutamate receptor functions (for review, see Conn and Pin, 1997;Anwyl, 1999;Cartmell and Schoepp, 2000).…”
Section: Subcellular Localization Of Kainate Receptor Subunitsmentioning
confidence: 58%
“…The ultrastructural analysis based on transmitter and receptor immunocytochemistry has repeatedly demonstrated short distance transmitter/receptor mismatches for the peptide and classical transmitters with the receptor labeling outside synapses (Dana et al, 1989;Pasquini et al, 1992;Levey et al, 1993;Liu et al, 1994;Sesack et al, 1994;Aoki, 1992;Aoki and Pickel, 1992;Yung et al, 1995;Caillé et al, 1996;Aoki et al, 1998;Azmitia and Whitaker-Azmitia, 1991;Azmitia et al, 1996;Boudin et al, 1998;Baude and Shigemoto, 1998;Dournaud et al, 1998). Extrasynaptic location of receptors has been observed mainly for G-protein-coupled receptors, but also for ion channel linked receptors .…”
Section: Location Of Transmitter Receptors Outside the Postsynaptic Dmentioning
confidence: 99%
“…Ultrastructural localization using electron microscopy immunogold, photoaffinity-labeled receptors with [ 125 I]-DTLET and biochemical subcellular fractionation techniques reveal that the majority of DOPrs are localized predominantly to intracellular sites, with only a small subset of DOPrs found in association with neuronal plasma membranes throughout the central and peripheral nervous systems (Pasquini et al, 1992;Zerari et al, 1994;Arvidsson et al, 1995;Cheng et al, 1995Cheng et al, , 1997Elde et al, 1995;Zhang et al, 1998;PetajaRepo et al, 2000;Cahill et al, 2001b;Commons et al, 2001;Wang and Pickel, 2001;Petäjä-Repo et al, 2002Commons, 2003;Guan et al, 2005;Lucido et al, 2005;Gendron et al, 2006). The small number of plasma membrane-bound receptors is consistent with the observation that DOPr agonists have modest effects in modulating nociception and reward (Cahill et al, 2007;Pradhan et al, 2011); however, systemic administration of DOPr agonists such as SNC80 produces locomotor hyperactivity, anxiolytic effects, antidepressant effects, and absence seizures (Pradhan et al, 2011;Chu Sin Chung and Kieffer, 2013;Gendron et al, 2015).…”
mentioning
confidence: 99%